Venture Round - Pneumagen
Investment Firm
Overview
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
Announced Date
Jun 01, 2023
Funding Type
Series Unknown
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 Esperante Ventures |
Round Details and Background
Pneumagen raised $10021032 on 2023-06-01 in Venture Round
Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 27, 2020 |  Venture Round - Pneumagen | 3 | - | 4.9M |
| Jan 21, 2021 | Venture Round - Pneumagen | 2 | - | 3.4M |
| Jan 19, 2022 | Venture Round - Pneumagen | 2 | - | 5.2M |
| Jun 01, 2023 | Venture Round - Pneumagen | 3 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.